• Pro-Dex posted fiscal 2026 third-quarter net income of $3.9 million, or $1.20 per diluted share.
• Net sales rose 15% to $19.9 million.
• Operating income fell 15% to $3.1 million as operating expenses climbed 41% to $3 million on acquisition-related costs and higher personnel expenses.
• Results included a $2.3 million realized gain from payment of contingent value rights tied to Monogram Technologies’ prior acquisition by Zimmer Biomet.
• Management said quarterly revenue set a record and highlighted completion of the Advanced Precision Machining acquisition, positioning the company for sustained success for the remainder of the fiscal year and beyond.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pro-Dex Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202604301600ACCESSWRNAPR_____1162254) on April 30, 2026, and is solely responsible for the information contained therein.